Edgewell Personal Care cuts FY25 adjusted EPS view to $2.65 from $2.85-$3.05

Consensus $2.90. Cuts FY25 adjusted EBITDA view to $312M from $329M-$341M. Sees FY25 capital expenditures 2.5%-3% of net sales. Sees FY25 free cash flow $80M. The company said, “Despite these transitory headwinds, we continued strong performance in our International business with growth and strengthened market share, and strong supply chain execution led to further productivity gains. Importantly, in North America, we saw improved market share performance from targeted, stepped-up investments in Hawaiian Tropic, Cremo, and Hydro Silk brands, as we continued to take actions across the U.S. business to strengthen our portfolio for the longer term. While these investments weigh on profitability in the near term, they serve to strengthen our business and better position our portfolio for a stronger 2026 and beyond. I am confident that these changes, along with continued disciplined execution of our strategic priorities will drive significant value creation for our shareholders.”